Apparatus and method for controlling insulin infusion with state variable feedback

Patent metadata

Field	Value
Publication number	US-9440025-B2
Application number	US-201414276986-A
Country	US
Kind code	B2
Filing date	May 13, 2014
Priority date	Jun 3, 1999
Publication date	Sep 13, 2016
Grant date	Sep 13, 2016

Abstract

An infusion system, which may be a closed loop infusion system or “semi-closed-loop” system, uses state variable feedback to control the rate that fluid is infused into the body of a user. The closed loop infusion system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that are displayed or sounded or otherwise provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user. The sensor produces a sensor signal, which is representative of the condition of the user. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused as a bolus and to be removed from the basal delivery of the fluid.

First claim

What is claimed is:

1. An apparatus for infusing insulin into a body of a user, the apparatus comprising:
a housing;
a pump inside the housing for delivering insulin into the body of the user; and
at least one controller to control delivery of the insulin from the housing by the pump, wherein the at least one controller:
controls delivery of a basal amount of insulin to the body of the user at a predetermined basal rate;
determines at least one state variable, said at least one state variable being at least one of subcutaneous insulin concentration, plasma insulin concentration, and insulin effect;
determines, based on the at least one state variable, an additional amount of insulin to be delivered to the body of the user;
controls delivery of the determined additional amount of insulin to the body of the user; and
reduces the basal rate by the additional amount of insulin.

2. The apparatus according to claim 1 , wherein, to determine the additional amount of insulin, the controller uses at least one gain, wherein each of the at least one gains corresponds to one of the at least one state variables.

3. The apparatus according to claim 1 , wherein the controller further determines a bolus amount of insulin to be delivered to the body of the user.

4. The apparatus according to claim 3 , further including one or more input devices in the housing, wherein the controller provides a prompt to indicate that the bolus amount of insulin has been determined and receives an input from the one or more input devices to indicate that the bolus amount of insulin should be delivered to the body of the user.

5. The apparatus according to claim 3 , wherein the controller uses an obtained blood glucose concentration of the user to determine said bolus amount of insulin.

6. The apparatus according to claim 5 , wherein the controller includes a proportional plus, integral plus, derivative (PID) controller operable to generate a controller input based on the blood glucose concentration, generate commands from the controller input, and determine, based on the commands, the bolus amount of insulin to be delivered to the body of the user.

7. The apparatus according to claim 6 , wherein, to determine the bolus amount of insulin to be delivered to the body of the user, the PID controller further uses at least one preset PID controller gain selected such that the commands generated by the PID controller infuse insulin into the body of the user in response to a glucose concentration at a rate similar to the rate that beta cells would release insulin in an individual with a healthy normally functioning pancreas.

8. The apparatus according to claim 7 , wherein the at least one preset controller gain is selected by a method that includes the step of measuring an insulin response of at least one individual with a healthy normally functioning pancreas and calculating the at least one controller gain that causes the commands to substantially match the insulin response of the at least one individual.

Assignees

• Medtronic Minimed Inc

Inventors

• Kanderian Jr Sami S
• Steil Garry M

Classifications

• A61M5/14244

  adapted to be carried by the patient, e.g. portable on the body · CPC title

• A61B5/6849

  in combination with a needle set · CPC title

• A61M5/1582

  Double lumen needles · CPC title

• A61B5/14532

  for measuring glucose, e.g. by tissue impedance measurement · CPC title

• A61M2005/1726

  the body parameters being measured at, or proximate to, the infusion site · CPC title